| Multidrug-Resistant
TB (MDR TB) |
|
|
|
|
|
|
|
| • | Presents
difficult treatment problems |
|||||
| • | Treatment
must be individualized |
|||||
| • | Clinicians
unfamiliar with treatment of MDR TB should |
|||||
| seek
expert consultation |
||||||
| • | Always
use DOT to ensure adherence |
|||||